ArticleNature biotechnology2015
Illuminating the dark matter of shotgun proteomics.
Article in Nature biotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- End-to-end deep attention-based multitask pipeline for predicting uncertainty-quantified peptide properties from mass spectrometry data.Scientific reports · 2026Article
- Global trends in machine learning applications for single-cell transcriptomics research.Hereditas · 2025Article
- Post-translational modifications of proteins in cardiovascular diseases examined by proteomic approaches.The FEBS journal · 2025Review
- The Hunt Lab Guide to De Novo Peptide Sequence Analysis by Tandem Mass Spectrometry.Molecular & cellular proteomics : MCP · 2024Article
- Exploring Protein Post-Translational Modifications of Breast Cancer Cells Using a Novel Combinatorial Search Algorithm.International journal of molecular sciences · 2024Article
- Mzion enables deep and precise identification of peptides in data-dependent acquisition proteomics.Scientific reports · 2023Article
- Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors.Nature biotechnology · 2023Article
- Overview and considerations in bottom-up proteomics.The Analyst · 2023Review
- Enhanced Proteomic Data Analysis with MetaMorpheus.Methods in molecular biology (Clifton, N.J.) · 2023Article
- Insights Into the Biogenesis and Emerging Functions of Lipid Droplets From Unbiased Molecular Profiling Approaches.Frontiers in cell and developmental biology · 2022Review
- Robust unsupervised deconvolution of linear motifs characterizes 68 protein modifications at proteome scale.Scientific reports · 2021Article
- Multiomic Big Data Analysis Challenges: Increasing Confidence in the Interpretation of Artificial Intelligence Assessments.Analytical chemistry · 2021Article
- RawBeans: A Simple, Vendor-Independent, Raw-Data Quality-Control Tool.Journal of proteome research · 2021Article
- Methods for Proteogenomics Data Analysis, Challenges, and Scalability Bottlenecks: A Survey.IEEE access : practical innovations, open solutions · 2021Article
- A Critical Review of Bottom-Up Proteomics: The Good, the Bad, and the Future of this Field.Proteomes · 2020Review
- Focus on the spectra that matter by clustering of quantification data in shotgun proteomics.Nature communications · 2020Article
- TagGraph reveals vast protein modification landscapes from large tandem mass spectrometry datasets.Nature biotechnology · 2019Article
- Comprehensive identification of peptides in tandem mass spectra using an efficient open search engine.Nature biotechnology · 2018Article
- Top-Down Analysis of Branched Proteins Using Mass Spectrometry.Analytical chemistry · 2018Article
- Top-down characterization of endogenous protein complexes with native proteomics.Nature chemical biology · 2018Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
26154010What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.